Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$266 Sell
95
-2
-2% -$6 ﹤0.01% 3235
2026
Q1
$243 Hold
97
﹤0.01% 3148
2025
Q4
$299 Hold
97
﹤0.01% 3073
2025
Q3
$352 Hold
97
﹤0.01% 3116
2025
Q2
$407 Sell
97
-2
-2% -$8 ﹤0.01% 3045
2025
Q1
$331 Buy
99
+5
+5% +$20 ﹤0.01% 3029
2024
Q4
$391 Buy
+94
New +$394 ﹤0.01% 2987

Other funds holding EVO

SBI Securities's EVO Position: Q2 2026 in Review

SBI Securities reduced its Evotec (EVO) stake by 2.1% in Q2 2026, selling an estimated $6 and leaving 95 shares worth $266. The position accounts for ﹤0.01% of the portfolio, ranked #3235.

SBI Securities first reported a position in EVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $407 in Q2 2025. 34 funds tracked by Wall St. Rank hold EVO as of Q2 2026.

  • SBI Securities held 95 shares of Evotec worth $266 as of Q2 2026.
  • SBI Securities sold 2 Evotec shares in Q2 2026, an estimated $6.
  • Evotec made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3235 holding.
  • SBI Securities first reported a position in Evotec in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Evotec position peaked at $407 in Q2 2025.
  • 34 funds tracked by Wall St. Rank held Evotec as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.